You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雙鷺藥業(002038.SZ):擬出資4000萬元參與普樂康增資
格隆匯 06-21 20:13

格隆匯6月21日丨雙鷺藥業(002038.SZ)公佈,2024年6月21日,北京雙鷺藥業股份有限公司第九屆董事會第二次會議審議通過了《關於投資4,000萬元參與蘇州普樂康醫藥科技有限公司增資的議案》,公司將出資人民幣4,000萬元參與蘇州普樂康醫藥科技有限公司(以下簡稱“普樂康”)增資(其中人民幣450,980.39元將用於增加普樂康註冊資本,人民幣39,549,019.61元將用於增加普樂康資本公積金)。普樂康增資完成後註冊資本增加為383.3333333萬元,雙鷺藥業持有普樂康11.765%股權。公司後期將繼續與普樂康展開戰略合作,投資支持普樂康完成PHP1003項目和PHP0101項目包括臨牀試驗和工藝驗證等後續研發工作並視項目進展和投資情況確定增持普樂康公司股權及展開項目產業化和商業化等深度合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account